S Sugai

2.6k total citations
31 papers, 592 citations indexed

About

S Sugai is a scholar working on Immunology, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, S Sugai has authored 31 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 12 papers in Pathology and Forensic Medicine and 7 papers in Physiology. Recurrent topics in S Sugai's work include Lymphoma Diagnosis and Treatment (8 papers), Salivary Gland Disorders and Functions (7 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). S Sugai is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Salivary Gland Disorders and Functions (7 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). S Sugai collaborates with scholars based in Japan, United States and China. S Sugai's co-authors include S Konda, Tomomi Toyonaga, Ritsuko Yoshioka, Masayoshi Shichiri, Okio Hino, K Yamamura, Kuniya Abe, Sayaka Shimizu, Yuki Hirose and Shōji Shimizu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

In The Last Decade

S Sugai

28 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Sugai Japan 10 237 142 123 117 107 31 592
Otto Prümmer Germany 16 239 1.0× 114 0.8× 89 0.7× 215 1.8× 139 1.3× 42 798
M. Bunce United Kingdom 16 594 2.5× 93 0.7× 117 1.0× 178 1.5× 43 0.4× 29 974
T Ohnoshi Japan 14 100 0.4× 308 2.2× 192 1.6× 200 1.7× 71 0.7× 92 721
Michał Abel France 9 653 2.8× 146 1.0× 113 0.9× 165 1.4× 45 0.4× 12 979
Martin Birkhofer United States 9 371 1.6× 186 1.3× 88 0.7× 61 0.5× 71 0.7× 20 802
María Jesús Citores Spain 15 292 1.2× 103 0.7× 124 1.0× 83 0.7× 35 0.3× 37 595
Patricia Palladinetti Australia 9 202 0.9× 115 0.8× 127 1.0× 228 1.9× 20 0.2× 9 617
Judith Diment Israel 13 184 0.8× 113 0.8× 91 0.7× 83 0.7× 84 0.8× 28 578
Kazuhito Sugimura Japan 12 267 1.1× 133 0.9× 214 1.7× 209 1.8× 52 0.5× 21 759
Marilyne Sasportes France 14 551 2.3× 133 0.9× 137 1.1× 78 0.7× 189 1.8× 25 840

Countries citing papers authored by S Sugai

Since Specialization
Citations

This map shows the geographic impact of S Sugai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Sugai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Sugai more than expected).

Fields of papers citing papers by S Sugai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Sugai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Sugai. The network helps show where S Sugai may publish in the future.

Co-authorship network of co-authors of S Sugai

This figure shows the co-authorship network connecting the top 25 collaborators of S Sugai. A scholar is included among the top collaborators of S Sugai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Sugai. S Sugai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Lei, Yasufumi Masaki, Takafumi Kawanami, et al.. (2007). Cloning and expression of two human recombinant monoclonal Fab fragments specific for EBV viral capsid antigen. International Immunology. 19(3). 331–336. 6 indexed citations
2.
Huang, Mingguo, Hiroaki Ida, Makoto Kamachi, et al.. (2005). Detection of apoptosis-specific autoantibodies directed against granzyme B-induced cleavage fragments of the SS-B (La) autoantigen in sera from patients with primary Sjögren's syndrome. Clinical & Experimental Immunology. 142(1). 148–154. 23 indexed citations
3.
Wano, Yuji, Yasufumi Masaki, N. Ogawa, et al.. (2000). [Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto's disease) accompanied by hemophagocytosis and salivary gland swelling in a patient with systemic lupus erythematosus].. PubMed. 41(1). 54–60. 19 indexed citations
4.
Sugai, S, et al.. (1999). Epstein-Barr virus study in malignant lymphoma in Sjögren's syndrome.. PubMed. 69(3). 174–9. 8 indexed citations
5.
Sugai, S. (1998). [Selective IgM deficiency].. PubMed. 216–7.
6.
Sugai, S, et al.. (1996). [A case of Sjögren's syndrome with an eyelid tumor, a so-termed pseudolymphoma of the iacrimal gland].. PubMed. 36(1). 43–9. 5 indexed citations
7.
Saji, Hiroh, Etsuko Maruya, Yoshihide Ishikawa, et al.. (1996). The linkage disequilibria between TAP1, TAP2 and other HLA loci in japanese. A newly identified mutation of TAP2 and it's association with autoimmune disease. Human Immunology. 47(1-2). 67–67. 1 indexed citations
8.
Sugai, S, et al.. (1995). [Lymphoproliferative disorders in patients with Sjögren's syndrome--Vg gene rearrangement and expression of bcl-2 protein].. PubMed. 53(10). 2580–6.
9.
Toyonaga, Tomomi, Okio Hino, S Sugai, et al.. (1994). Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver.. Proceedings of the National Academy of Sciences. 91(2). 614–618. 174 indexed citations
10.
Sugai, S. (1992). Antiphospholipid antibody and antiphospholipid antibody syndrome.. PubMed. 4(5). 666–71. 2 indexed citations
11.
Takeuchi, Yu, et al.. (1992). [Malignant lymphoma developing from the wall of chronic empyema following artificial pneumothorax].. PubMed. 33(8). 1041–5. 1 indexed citations
12.
Shimizu, Sayaka, et al.. (1989). Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines.. The Journal of Experimental Medicine. 169(1). 339–344. 91 indexed citations
13.
Shimizu, Shōji, T Hirano, Ritsuko Yoshioka, et al.. (1988). Interleukin-6 (B-cell stimulatory factor 2)-dependent growth of a Lennert's lymphoma-derived T-cell line (KT-3). Blood. 72(5). 1826–1828. 70 indexed citations
14.
Shimizu, Shōji, T Hirano, Ritsuko Yoshioka, et al.. (1988). Interleukin-6 (B-cell stimulatory factor 2)-dependent growth of a Lennert's lymphoma-derived T-cell line (KT-3). Blood. 72(5). 1826–1828. 2 indexed citations
15.
Sugai, S, et al.. (1984). Idiotypic studies on monoclonal rheumatoid factors.. PubMed. 47(4). 1035–41. 1 indexed citations
16.
Sugai, S, T Takiguchi, & S Konda. (1984). Monoclonal immunoglobulins and B cell lymphoproliferative disorders.. PubMed. 47(8). 1604–15. 1 indexed citations
17.
Hamada, Atsuo, Toshihiro Haba, Takuya Kobayashi, et al.. (1983). [A case of IgA-kappa multiple myeloma with hyperviscosity syndrome terminating in plasma cell leukemia].. PubMed. 24(5). 572–9. 1 indexed citations
18.
Konda, S, et al.. (1981). A case of eosinophilic leukemia associated with Löffler's endocarditis. Clinical course and autopsy findings.. PubMed. 44(4). 902–9. 1 indexed citations
20.
Greenspan, John S., George A. Gutman, Norman Talal, Irving L. Weissman, & S Sugai. (1974). Thymus-antigen- and immunoglobulin-positive cells in lymph-nodes, thymus, and malignant lymphomas of NZB/NZW mice. PubMed. 3(1). 32–51. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026